{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:36:05Z","timestamp":1783740965774,"version":"3.55.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12328-025-02177-0","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:53:47Z","timestamp":1752141227000},"page":"799-807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Severe luminal stricture in immune-related adverse event-associated enteritis: a case report"],"prefix":"10.1007","volume":"18","author":[{"given":"Akifumi","family":"Fukui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7239-0066","authenticated-orcid":false,"given":"Yusuke","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Sawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Inada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Nakatsugawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Tomatsuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Urata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"2177_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","volume":"373","author":"J Larkin","year":"2015","unstructured":"Larkin J, Chiarion-Sileni V, Gonzalez R, et al. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Eugl J Med. 2015;373:23\u20134.","journal-title":"N Eugl J Med"},{"key":"2177_CR2","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S1470-2045(16)30126-7","volume":"17","author":"JS Weber","year":"2016","unstructured":"Weber JS, Gibney G, Sullivan RJ, et al. Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (Checkmate 064): an open-label, randomised, phase 2 trial. Lancet Oncol. 2016;17:943\u201355.","journal-title":"Lancet Oncol"},{"key":"2177_CR3","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1136\/gutjnl-2018-316948","volume":"67","author":"E Soularue","year":"2018","unstructured":"Soularue E, Lepage P, Colombel JF, et al. Enterocolitis due to immune checkpoint inhibitors: a systematic review. Gut. 2018;67:2056\u201367.","journal-title":"Gut"},{"key":"2177_CR4","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1053\/j.gastro.2020.08.063","volume":"160","author":"M Dougan","year":"2021","unstructured":"Dougan M, Wang Y, Rubin-Tapia A, et al. AGA clinical practice update on diagnosis and management of immune checkpoint inhibitor colitis and hepatitis: expert review. Gastroenterology. 2021;160:1284\u201393.","journal-title":"Gastroenterology"},{"key":"2177_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12885-015-1074-7","volume":"15","author":"O Venditti","year":"2015","unstructured":"Venditti O, De Lisi D, Caricato M, et al. Ipilimumab and immune-mediated adverse events: a case report of anti-CTLA4 induced ileitis. BMC Cancer. 2015;15:87.","journal-title":"BMC Cancer"},{"key":"2177_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-224913","author":"AA Suwaidan","year":"2018","unstructured":"Suwaidan AA, Richards CJ, Boyle K, et al. Severe inflammatory ileitis resulting in ileal perforation in association with combination immune checkpoint blockade for metastatic malignant melanoma. BMJ Case Rep. 2018. https:\/\/doi.org\/10.1136\/bcr-2018-224913.","journal-title":"BMJ Case Rep"},{"key":"2177_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.vgie.2018.11.005","volume":"4","author":"SCL Smith","year":"2019","unstructured":"Smith SCL, Zardo D, Cannatelli R, et al. Endoscopic findings of checkpoint inhibitor-induced ileitis with use of the latest advanced endoscopic optical diagnosis: near-focus narrow-band imaging. VideoGIE. 2019;4:133\u20135.","journal-title":"VideoGIE"},{"key":"2177_CR8","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/jgh3.12392","volume":"4","author":"S Otagiri","year":"2020","unstructured":"Otagiri S, Katsurada T, Yamanashi K, et al. Immune checkpoint inhibitor-induced enteritis assessed using capsule endoscopy. JGH Open. 2020;4:1231\u20132.","journal-title":"JGH Open"},{"key":"2177_CR9","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1344805","author":"DY Wang","year":"2017","unstructured":"Wang DY, Ye F, Zhao S, et al. Incidence of immune checkpoint inhibitor-related colitis in solid tumor patients: a systematic review and meta-analysis. Oncoimmunology. 2017. https:\/\/doi.org\/10.1080\/2162402X.2017.1344805.","journal-title":"Oncoimmunology"},{"key":"2177_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/CJI.0000000000000213","volume":"41","author":"P Tandon","year":"2018","unstructured":"Tandon P, Bourassa-Blanchette S, Bishay K, et al. The risk of diarrhea and colitis in patients with advanced melanoma undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis. J Immunother. 2018;41:101\u20138.","journal-title":"J Immunother"},{"key":"2177_CR11","doi-asserted-by":"publisher","first-page":"e009051","DOI":"10.1136\/jitc-2024-009051","volume":"12","author":"PT Magahis","year":"2024","unstructured":"Magahis PT, Corso T, Livingstone P, et al. Open-capsule budesonide for the treatment of immune-related enteritis from checkpoint inhibitors. J Immunother Cancer. 2024;12:e009051.","journal-title":"J Immunother Cancer"},{"key":"2177_CR12","doi-asserted-by":"publisher","first-page":"102311","DOI":"10.1016\/j.clinre.2024.102311","volume":"48","author":"M Jeay","year":"2024","unstructured":"Jeay M, Carbonnel F, Robert C, et al. Chronic gastrointestinal immune-related adverse events in patients exposed to immune checkpoint inhibitors. Clin Res Hepatol Gastroenterol. 2024;48:102311.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2177_CR13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/ajcp\/aqaa217","volume":"156","author":"YC Lo","year":"2021","unstructured":"Lo YC, Price C, Blenman K, et al. Checkpoint inhibitor colitis shows drug-specific differences in immune cell reaction that overlap with inflammatory bowel disease and predict response to colitis therapy. Am J Clin Pathol. 2021;156:214\u201328.","journal-title":"Am J Clin Pathol"},{"key":"2177_CR14","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00428-021-03170-x","volume":"479","author":"S Hone Lopez","year":"2021","unstructured":"Hone Lopez S, Kats-Ugurlu G, Renken RJ, et al. Immune checkpoint inhibitor treatment induces colitis with heavy infiltration of CD8 + T cells and an infiltration pattern that resembles ulcerative colitis. Virchows Arch. 2021;479:1119\u201329.","journal-title":"Virchows Arch"},{"key":"2177_CR15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10620-022-07598-2","volume":"68","author":"Y Takahashi","year":"2023","unstructured":"Takahashi Y, Nagaya T, Iwaya Y, et al. CD8+ Lymphocyte infiltration is a specific feature of colitis induced by immune checkpoint inhibitors. Dig Dis Sci. 2023;68:451\u20139.","journal-title":"Dig Dis Sci"},{"key":"2177_CR16","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1093\/ibd\/izy104","volume":"24","author":"Y Wang","year":"2018","unstructured":"Wang Y, Abu-Sbeih H, Mao E, et al. Endoscopic and histologic features of immune checkpoint inhibitor-related colitis. Inflamm Bowel Dis. 2018;24:1695\u2013705.","journal-title":"Inflamm Bowel Dis"},{"key":"2177_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/bjs.5464","volume":"94","author":"D Hahnloser","year":"2007","unstructured":"Hahnloser D, Pemberton JH, Wolff BG, et al. Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Br J Surg. 2007;94:333\u201340.","journal-title":"Br J Surg"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-025-02177-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-025-02177-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-025-02177-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:21:00Z","timestamp":1758813660000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-025-02177-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2177"],"URL":"https:\/\/doi.org\/10.1007\/s12328-025-02177-0","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from the patient for the publication of his de-identified data and images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}